MENU
Advertisement
View PDF Reprints
View Supplement
Pharmacologic Options for Treating Restenosis
By Osamu Iida, MD, and Yoshimitsu Soga, MD
left-arrow Created with Sketch. Previous Article
Comparing SFA Device Trials
By Michael R. Jaff, DO
Next Article right-arrow Created with Sketch.
The Restenosis Conundrum
How are reoccuring lesions in the SFA best treated and managed?
View Issue
Achieving Durable Results Above the Knee
By Michael L. Campbell, MD
Pedal Disease: Can Vessel Remodeling Improve Distal Revascularization?
By Melissa Keller, MD, PhD
SRT for PTAB: Predictable Lumen Expansion to Facilitate Percutaneous Transmural Arterial Bypass
By David O’Connor, MD
Improving PAD Awareness, Access, and Amputation Prevention
With Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM
Expanding Neurovascular Applications of the Swift™ Coil System
With Mohsen Nouri, MD; Robert M. Starke, MD; Allison E. Strickland, MD; and Nitin Goyal, MD
The 2026 AHA/ACC Guideline for the Management of Acute Pulmonary Embolism
By Geoffrey D. Barnes, MD, MSc; Allison Burnett, PharmD; Jay Giri, MD, MPH; and Soophia Naydenov, MD
Three Keys to Creating and Maturing pAVFs for Successful Cannulation Safety
By Rishi Razdan, MD
Simplifying PE Treatment: Real-World Experience With the AVENTUS® Thrombectomy System
With Austin Bourgeois, MD; Thomas Wong, MD; Ripal T. Gandhi, MD, FSVM, FSIR; and Patrick Muck, MD
